Compare Enzyme (MLN) vs SUPRA (SUPRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs SUPRA — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while SUPRA trades at Rp3.78 (market cap Rp122,28M, Rp5,07M 24h volume). The key difference: Enzyme and SUPRA are close in size by market cap, and SUPRA's supply is capped (32,5B / 100B SUPRA (33%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and SUPRA for 15 Days on average.
| MLN | SUPRA | |
|---|---|---|
Market Cap | Rp134,13M | Rp122,28M |
Volume (24h) | Rp104,56M | Rp5,07M |
Circulating Supply | 3,3M MLN | 32,5B / 100B SUPRA (33%) |
Typical Hold Time | 28 Days | 15 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
SUPRA is currently trading at Rp3.6929 with a market cap of Rp119.88 million, showing a bearish technical signal driven by moving averages while oscillators remain neutral. The token has a circulating supply of 32.5 million out of 100 million max supply, with an average hold time of 15 days indicating moderate trader retention. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook remains cautious due to strong bearish technical indicators and limited fundamental catalysts. Key opportunities include potential accumulation at current levels if network activity improves, while major risks involve low liquidity and high volatility typical of small-cap cryptocurrencies. Investors should monitor for any upcoming protocol announcements or exchange listings.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About SUPRA
Supra is the first blockchain built for Automatic DeFi (AutoFi), an automated financial system. As a Layer-1 solution, it supports high-speed smart contracts with integrated data and AI oracles, automation, and cross-chain messaging. This allows for innovative AutoFi features that generate revenue and redistribute it to applications and node operators, reducing reliance on block rewards over time. The Supra stack also provides AI agents with the tools needed to create and execute effective AutoFi strategies for users in a fully on-chain, secure, and autonomous manner.
Read more on SUPRA →
